ArticleTranslational lung cancer research2019

Can PD-L1 tumor proportion score be used as the key to unlocking the KEYNOTE studies of pembrolizumab in advanced lung cancer?

Andrew J Piper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.